| Literature DB >> 32146895 |
Mathias Basner1, Daniel W Riggs2,3,4,5, Daniel J Conklin2,3,4,6.
Abstract
Entities:
Keywords: Editorials; air pollution; diabetes mellitus; hypertension; noise; sleep disturbance; traffic
Year: 2020 PMID: 32146895 PMCID: PMC7335518 DOI: 10.1161/JAHA.120.016048
Source DB: PubMed Journal: J Am Heart Assoc ISSN: 2047-9980 Impact factor: 5.501
Figure 1Environmental determinants of cardiometabolic disease include noise and traffic‐derived air pollutants (ultrafine particles, UFP; nitrogen dioxide, NO 2). Noise had a stronger effect on hypertension and type 2 diabetes mellitus (T2D) during the nighttime than during the daytime or when levels of UFP and NO 2 were higher. Individual level (personal domain) risk factors (obesity, smoking) did not substantially alter these associations. This study clearly suggests that the effects of chronic noise on incident T2D and hypertension depend on the levels of UFP and NO 2, but the exact nature of this relationship warrants further investigation. Future prospective, longitudinal studies with noise as the primary exposure of interest (and not just as an afterthought) as well as animal studies using appropriate chronic noise exposure conditions are required to disentangle the effects of simultaneous exposures to air pollution and noise. Arrows represent environmental determinants (black) and pathways into (afferent; blue) and away from (efferent; red) the central nervous system (CNS: brain and spinal cord) that may contribute to cardiometabolic disease. As depicted, it is thought that noise stimulates an auditory afferent that activates the amygdala, and subsequent efferent output from the autonomic nervous system (ANS) includes both (1) release of corticotropic releasing hormone (hypothalamus) and then increased cortisol (adrenal cortex); and, (2) neurally‐triggered catecholamine release (adrenal medulla). Likewise, both pulmonary and olfactory sensory afferents are implicated in mediating air pollution exposure–dependent CNS activation with efferents likely including both ANS stimulation (a shared pathway with noise) and release of circulating inflammatory mediators. Collectively, these efferents mediate systemic “stress responses” that may increase insulin resistance, inflammation, disturb sleep, etc. It is possible that answers to the questions about how these determinants actually promote cardiometabolic disease may well be found “in the noise.”